sponsored
PatientsVille.com Logo

PatientsVille

Duodart Side Effects Poll Results

Our Users Report - Have you experienced Duodart side effects?

148 user poll responses

Loading...

« go back

Duodart Common Side Effects

The most commonly reported Duodart side effects (click to view or check a box to report):

Dizziness (7)
Malaise (6)
Dyspnoea (4)
Rash Pruritic (3)
Myalgia (3)
Hypersensitivity (3)
Fall (3)
Loss Of Consciousness (2)
Bronchospasm (2)
Hepatic Enzyme Increased (2)
Hypotension (2)
Pyrexia (2)
Product Quality Issue (2)
Syncope (2)
Tachycardia (2)
Urinary Retention (2)
Withdrawal Syndrome (1)
Abnormal Faeces (1)
Anorectal Discomfort (1)
Asthenia (1)

➢ More


If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Dizziness (7)
Malaise (6)
Dyspnoea (4)
Rash Pruritic (3)
Myalgia (3)
Hypersensitivity (3)
Fall (3)
Bronchospasm (2)
Hepatic Enzyme Increased (2)
Hypotension (2)
Loss Of Consciousness (2)
Pyrexia (2)
Syncope (2)
Tachycardia (2)
Urinary Retention (2)
Product Quality Issue (2)
Bladder Dysfunction (1)
Abnormal Faeces (1)
Anorectal Discomfort (1)
Asthenia (1)
Ataxia (1)
Atrial Fibrillation (1)
Defaecation Urgency (1)
Blood Pressure Decreased (1)
Blood Pressure Increased (1)
Breast Pain (1)
Cardiomyopathy (1)
Cardiovascular Disorder (1)
Chest Discomfort (1)
Deafness (1)
Dry Mouth (1)
Diarrhoea (1)
Faeces Discoloured (1)
Dysuria (1)
Eczema (1)
Erythema (1)
Erectile Dysfunction (1)
Epilepsy (1)
Eosinophilia (1)
Eosinophil Count Increased (1)
Electrocardiogram Qrs Complex Shortened (1)
Erythema Multiforme (1)
Gastrooesophageal Reflux Disease (1)
Face Oedema (1)
Faeces Soft (1)
Fatigue (1)
Food Interaction (1)
Gastric Disorder (1)
Gastrointestinal Haemorrhage (1)
Dermatitis Bullous (1)

➢ More

sponsored

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.


Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Some can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

Up-to-date List of Duodart Research Studies

Rank Status Study
1 Recruiting Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
Outcome Measures: Use the number of participants with adverse events,serious adverse events and treatment-related adverse events as a measure of Safety;   Use changes in International Prostate symptom score (IPSS) and Qmax (Maximum rate of Urinary Flow (ml/sec) as a measure of Efficacy
2 Recruiting Prospective Sexual Function Study for BPH Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride plus tamsulosin;   Drug: Placebo
Outcome Measures: Changes in total score from the full men's sexual health questionnaire (MSHQ) which has domains for erectile dysfunction, ejaculatory function and libido.;   Change in scores from the full Men's Sexual Health Questionnaire (MSHQ) from baseline at 1, 3, 6 and 9 months;   The percentage of subjects reaching the following thresholds: +10 points, +20 points,+25 points, -10 points, -20 points, -25 points, change in total MSHQ from baseline at 12 months;   Change in scores from ED, EjD and libido domains from baseline at 1, 3, 6, 9 and 12 months.;   Change in scores from baseline IPSS questionnaire scores, Quality of Life (BPH Impact Index -BII scores) and perception of treatment benefit/satisfaction with treatment (PPSM questionnaire scores) at 2 weeks an 1, 3, 6 ,9 and 12 months;   Change in MSHQ scores from baseline at 12 months in subpopulations of men with good BPH symptomatic response;   Assess the duration of events both during the treatment phase and after treatment discontinuation by following up men with sexual adverse events who withdraw from the study or men with sexual apresent at the last visit of the treatment phase

Duodart Patient Forum